{
    "organizations": [],
    "uuid": "8758a6e7ee8f33666452b2ec8c75c788df201d56",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-vistagen-therapeutics-receives-not/brief-vistagen-therapeutics-receives-notice-of-allowance-for-a-key-u-s-patent-covering-treatment-of-depression-idUSFWN1QP0LC",
    "ord_in_thread": 0,
    "title": "BRIEF-Vistagen Therapeutics Receives Notice Of Allowance For A Key U.S. Patent Covering Treatment Of Depression",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "March 7 (Reuters) - Vistagen Therapeutics Inc:\n* VISTAGEN THERAPEUTICS RECEIVES NOTICE OF ALLOWANCE FOR A KEY U.S. PATENT COVERING TREATMENT OF DEPRESSION WITH AV-101 Source text for Eikon: Further company coverage: (Reuters.Brief@thomsonreuters.com)\n ",
    "published": "2018-03-07T22:06:00.000+02:00",
    "crawled": "2018-03-08T17:38:37.015+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "march",
        "reuters",
        "vistagen",
        "therapeutic",
        "inc",
        "vistagen",
        "therapeutic",
        "receives",
        "notice",
        "allowance",
        "key",
        "patent",
        "covering",
        "treatment",
        "depression",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}